Trials / Completed
CompletedNCT01851772
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Xoft, Inc. · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety, performance and usability of the Xoft Axxent Electronic Brachytherapy System and Cervical Applicator as incorporated into the physician's current standard treatment practice and in replacement of high-dose-rate after-loaders using Iridium-192 or low-dose-rate Cesium treatments. Data will be collected on treatment delivery, safety, and acute toxicity. Our hypothesis is that the treatment is safe as incorporated into the physician's current standard of practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Treatment with Electronic Brachytherapy |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2013-05-10
- Last updated
- 2021-01-12
- Results posted
- 2016-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01851772. Inclusion in this directory is not an endorsement.